학술논문

Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE)
Document Type
Article
Source
In: Breast Cancer Research. (Breast Cancer Research, December 2023, 25(1))
Subject
Language
English
ISSN
1465542X
14655411